These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 27341022)

  • 1. Characterisation of the oxysterol metabolising enzyme pathway in mismatch repair proficient and deficient colorectal cancer.
    Swan R; Alnabulsi A; Cash B; Alnabulsi A; Murray GI
    Oncotarget; 2016 Jul; 7(29):46509-46527. PubMed ID: 27341022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expression and prognostic significance of retinoic acid metabolising enzymes in colorectal cancer.
    Brown GT; Cash BG; Blihoghe D; Johansson P; Alnabulsi A; Murray GI
    PLoS One; 2014; 9(3):e90776. PubMed ID: 24608339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The differential expression of omega-3 and omega-6 fatty acid metabolising enzymes in colorectal cancer and its prognostic significance.
    Alnabulsi A; Swan R; Cash B; Alnabulsi A; Murray GI
    Br J Cancer; 2017 Jun; 116(12):1612-1620. PubMed ID: 28557975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intratumoral budding as a potential parameter of tumor progression in mismatch repair-proficient and mismatch repair-deficient colorectal cancer patients.
    Lugli A; Vlajnic T; Giger O; Karamitopoulou E; Patsouris ES; Peros G; Terracciano LM; Zlobec I
    Hum Pathol; 2011 Dec; 42(12):1833-40. PubMed ID: 21664647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urokinase-type plasminogen activator is a marker of aggressive phenotype and an independent prognostic factor in mismatch repair-proficient colorectal cancer.
    Minoo P; Baker K; Baumhoer D; Terracciano L; Lugli A; Zlobec I
    Hum Pathol; 2010 Jan; 41(1):70-8. PubMed ID: 19740518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic assessment of protein phenotypes characterizing high-grade tumour budding in mismatch repair-proficient colorectal cancer.
    Karamitopoulou E; Lugli A; Panayiotides I; Karakitsos P; Peros G; Rallis G; Patsouris ES; Terracciano L; Zlobec I
    Histopathology; 2010 Aug; 57(2):233-43. PubMed ID: 20716165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of an oxysterol-metabolizing enzyme in colorectal cancer and its relation to tumor cell behavior and prognosis.
    Kim KH; Park YL; Park SY; Joo YE
    Pathol Res Pract; 2023 Nov; 251():154875. PubMed ID: 37820439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the immunological microenvironment of tumour buds and its impact on prognosis in mismatch repair-proficient and -deficient colorectal cancers.
    Zlobec I; Minoo P; Terracciano L; Baker K; Lugli A
    Histopathology; 2011 Sep; 59(3):482-95. PubMed ID: 22034888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial oxysterol biosynthetic pathway gives evidence for CYP7B1 as controller of regulatory oxysterols.
    Kakiyama G; Marques D; Takei H; Nittono H; Erickson S; Fuchs M; Rodriguez-Agudo D; Gil G; Hylemon PB; Zhou H; Bajaj JS; Pandak WM
    J Steroid Biochem Mol Biol; 2019 May; 189():36-47. PubMed ID: 30710743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor Budding and PDC Grade Are Stage Independent Predictors of Clinical Outcome in Mismatch Repair Deficient Colorectal Cancer.
    Ryan É; Khaw YL; Creavin B; Geraghty R; Ryan EJ; Gibbons D; Hanly A; Martin ST; O'Connell PR; Winter DC; Sheahan K
    Am J Surg Pathol; 2018 Jan; 42(1):60-68. PubMed ID: 29112018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deficient mismatch repair phenotype is a prognostic factor for colorectal cancer in elderly patients.
    Aparicio T; Schischmanoff O; Poupardin C; Soufir N; Angelakov C; Barrat C; Levy V; Choudat L; Cucherousset J; Boubaya M; Lagorce C; Guetz GD; Wind P; Benamouzig R
    Dig Liver Dis; 2013 Mar; 45(3):245-50. PubMed ID: 23102497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of cell cycle and apoptosis regulatory proteins in mismatch repair-proficient colorectal cancer: a tissue microarray-based approach.
    Tornillo L; Lugli A; Zlobec I; Willi N; Glatz K; Lehmann F; Spichtin HP; Maurer R; Stoios D; Sauter G; Terracciano L
    Am J Clin Pathol; 2007 Jan; 127(1):114-23. PubMed ID: 17145638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of APAF-1 expression is associated with tumour progression and adverse prognosis in colorectal cancer.
    Zlobec I; Minoo P; Baker K; Haegert D; Khetani K; Tornillo L; Terracciano L; Jass JR; Lugli A
    Eur J Cancer; 2007 Apr; 43(6):1101-7. PubMed ID: 17350821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and molecular characterisation of hereditary and sporadic metastatic colorectal cancers harbouring microsatellite instability/DNA mismatch repair deficiency.
    Cohen R; Buhard O; Cervera P; Hain E; Dumont S; Bardier A; Bachet JB; Gornet JM; Lopez-Trabada D; Dumont S; Kaci R; Bertheau P; Renaud F; Bibeau F; Parc Y; Vernerey D; Duval A; Svrcek M; André T
    Eur J Cancer; 2017 Nov; 86():266-274. PubMed ID: 29055842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An alternative pathway in colorectal carcinogenesis based on the mismatch repair system and p53 expression in Korean patients with sporadic colorectal cancer.
    Kim HR; Kim HC; Yun HR; Kim SH; Park CK; Cho YB; Yun SH; Lee WY; Chun HK
    Ann Surg Oncol; 2013 Nov; 20(12):4031-40. PubMed ID: 22732839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in brain oxysterols at different stages of Alzheimer's disease: Their involvement in neuroinflammation.
    Testa G; Staurenghi E; Zerbinati C; Gargiulo S; Iuliano L; Giaccone G; Fantò F; Poli G; Leonarduzzi G; Gamba P
    Redox Biol; 2016 Dec; 10():24-33. PubMed ID: 27687218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic impact of β-2-microglobulin expression in colorectal cancers stratified by mismatch repair status.
    Koelzer VH; Baker K; Kassahn D; Baumhoer D; Zlobec I
    J Clin Pathol; 2012 Nov; 65(11):996-1002. PubMed ID: 22859396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of mammalian sterile20-like kinase 1 in colorectal cancer.
    Minoo P; Zlobec I; Baker K; Tornillo L; Terracciano L; Jass JR; Lugli A
    Mod Pathol; 2007 Mar; 20(3):331-8. PubMed ID: 17277767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of oxysterol pathway genes in oestrogen-positive breast carcinomas.
    Kloudova A; Brynychova V; Vaclavikova R; Vrana D; Gatek J; Mrhalova M; Kodet R; Soucek P
    Clin Endocrinol (Oxf); 2017 Jun; 86(6):852-861. PubMed ID: 28342201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epithelial-mesenchymal transition (EMT) protein expression in a cohort of stage II colorectal cancer patients with characterized tumor budding and mismatch repair protein status.
    Kevans D; Wang LM; Sheahan K; Hyland J; O'Donoghue D; Mulcahy H; O'Sullivan J
    Int J Surg Pathol; 2011 Dec; 19(6):751-60. PubMed ID: 21791486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.